Skip to main content
. 2020 Dec 19;10(3):923–932. doi: 10.1002/cam4.3675

Figure 3.

Figure 3

Subgroup analyses of overall survival in stage IV non‐small cell lung cancer patients with brain metastases according to each clinical factor are shown. HR, hazard ratio; NOS,, adenocarcinoma, not otherwise specified